ALBANY, N.Y. (July 2020) — Technology and expertise residing in Albany’s RNA Institute was recently featured in the highly acclaimed and international journal Nature. One of the authors and RNA expert Dr. Qishan Lin developed key enabling technology at the RNA Epitranscriptomic and Proteomic Resource (REPR) housed at UAlbany’s RNA Institute to contribute to the paper. Titled “Dynamic RNA acetylation revealed by quantitative cross-evolutionary mapping”, the study provides a technical and conceptual foundation for elucidating the role of molecular marks in biology and disease.
Dr. Lin is a Research Associate Professor of Biomedical Sciences and Chemistry, member of the RNA Institute and Operations Director at REPR, and his lab develops highly sensitive ultra-performance liquid chromatography coupled with mass spectrometry to analyze very low level RNA modifications, as well as proteins. In layperson terms – Dr. Lin can find the needle in the haystack! RNA Institute Director and Professor of Biological Sciences Andy Berglund said “Dr. Qishan Lin is an outstanding RNA scientist that works with many in our community and his collaborative work has contributed to grants, papers and technology development throughout his career. We congratulate him on this outstanding accomplishment!”.
Link to article: https://www.nature.com/articles/s41586-020-2418-2
The RNA Epitranscriptomics & Proteomics Resource (REPR) at the RNA Institute is a joint venture between the VPR office and the Dean of the College of Arts and Sciences. The primary function of the resource is to provide access to advanced mass spectrometry instrumentation and highly trained personnel to advance UAlbany research enterprise.
About the RNA Institute
The RNA Institute at the University At Albany, NY, develops and delivers tools, analytics and early stage discoveries necessary for the progression of RNA-based therapeutics and diagnostics. It brings together leading researchers from higher education and other institutions and industry and offers advanced facilities for RNA research that are critical to new frontiers in human health.